Duncan Sim

• Health & Medicine

New breed of personalised cancer medicine approved in England. What does it mean for patients?

A new breed of targeted cancer drug has been approved for NHS use in England. But drugs like larotrectinib also pose unique and complex challenges for the NHS, which have been exacerbated by the COVID-19 pandemic. A new breed of targeted cancer drug has been approved for NHS use in England. But drugs like larotrectinib also pose unique and complex challenges for the NHS, which have been exacerbated by the COVID-19 pandemic.

21 April 2020

• Health & Medicine

NHS to ‘fast track’ new personalised cancer medicines – but it’s not ready quite yet

NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients. NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.

19 June 2019

• Health & Medicine

Linking cancer drug prices to treatment success could speed up approvals. But what do patients consider success?

With NHS budgets stretched, it’s critical that cancer drugs offer value for money. We’ve teamed up with the Greater Manchester Health and Social Care Partnership to investigate a different approach to drug pricing. With NHS budgets stretched, it’s critical that cancer drugs offer value for money. We’ve teamed up with the Greater Manchester Health and Social Care Partnership to investigate a different approach to drug pricing.

21 February 2019

• Health & Medicine

The new Cancer Drugs Fund has quietly reached a significant milestone

A revamped Cancer Drugs Fund is giving patients new options and renewed chances of successful treatment, quicker than ever before. A revamped Cancer Drugs Fund is giving patients new options and renewed chances of successful treatment, quicker than ever before.

14 December 2018

• Health & Medicine

‘Cutting edge’ CAR T cell immunotherapy approved in England. But is the NHS ready?

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments. With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

5 October 2018